267
Views
2
CrossRef citations to date
0
Altmetric
CASE REPORT

Managing Helicobacter pylori in college health, with special considerations for international students

, MD & , MD
Pages 404-408 | Received 28 Jul 2014, Accepted 16 Aug 2015, Published online: 10 May 2016

References

  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–1315.
  • Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet. 2009;374:1449–1461.
  • Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am. 2010;24:853–869.
  • Overland MK. Dyspepsia. Med Clin North Am. 2014;98:549–564.
  • Den Hollander WJ, Sostres C, Kuipers EJ, et al. Helicobacter pylori and non-malignant diseases. Helicobacter. 2013;18(Suppl 1):24–27.
  • Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38:329–342.
  • Peleteiro B, Bastos A, Ferro A, et al. Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with coverage worldwide. Dig Dis Sci. 2014; 59:1698–1709.
  • Project Atlas. International students in the United States. Available at: http://www.iie.org/Services/Project-Atlas/United-States/International-Students-In-US. Accessed July 1, 2015.
  • Fock KM, Ang TL. Epidemiology of Helico bacter pylori infection and gastric cancer in Asia. J Gastroenterol Hepatol. 2010;25:479–486.
  • Ozaydin N, Turkyilimaz, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with13 C-Urea Breath Test. BMC Public Health. 2013;13:1215.
  • Sullivan T, Ashbury FD, Fallone CA, et al. Helicobacter and the prevention of gastric cancer. Can J Gastroenterol. 2004;18:295–302.
  • Marie MA. Seroprevalence of Helicobacter pylori infection in a large series of patients in an urban area of Saudi Arabia. Korean J Gastroenterol. 2008;52:226–229.
  • Stewart BW, Wild CP. World Cancer Report 2014. Lyon, France: World Health Organization; 2014:19
  • Chey WD, Wong BY American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gasteroenterol. 2007;102:1808–1825.
  • American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology. 2005; 129:1753–1755.
  • Siao D, Somsouk M. Helicobacter pylori: evidence-based review with a focus on immigrant populations. J Gen Int Med. 2014;29:520–528.
  • Dalal RS, Moss SF. H. pylori dysregulated host responses, DNA damage, and gastrointestinal cancer. J Leukoc Biol. 2014; 96(2):201–212.
  • Lee YC, Liou JM, Wu MS, et al. Eradication of Helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. Ther Adv Gastroenterol. 2008;1:111–120.
  • Ford AC, Forman D, Hunt RH, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic individuals: systematic review and meta-analysis of randomized controlled trials. BMJ. 2014;348:g3174.
  • Blacer MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis. 1999;179:1523–1530.
  • Lee YY, Mahendra RS, Graham DY. Helicobacter pylori—a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter. 2013;18:338–346.
  • Ferro A, Peleteiro B, Malvezzi, et al. Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, incidence by subtype. Eur J Cancer. 2014;50:1330–1344.
  • Fock KM, Tally N, Moayyedi P, et al. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gasterenterol Hepatol. 2008;23:351–365.
  • Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646–664.
  • Gisbert JP, Calvert X. Helicobacter pylori “Test-and-Treat” strategy for management of dyspepsia: a comprehensive review. Clin Transl Gastroenterol. 2013;4:e32.
  • Adachi M, Mizuno M, Yokota K, et al. Reinfection rate following effective therapy against Helicobacter pylori infection in Japan. J Gastroenterol Hepatol. 2002;17:27–31.
  • Graham DY, Fischbach LA. Empiric therapies for Helicobacter pylori infections. CMAJ. 2011; 183:E506–E508.
  • Hunt RH, Xiao SD, Megraud F, et al. Helicobacter pylori in developing countries. World Gastroenterology Organization global guideline. J Gastrointest Liver Dis. 2011;20:299–304.
  • Okamura T, Suga T, Nagaya T, et al. Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison. Helicobacter. 2014;19:214–220.
  • Wu JY, Liou JM, Graham DY. Evidence-based recommendations for successful Helicobacter pylori treatment. Expert Rev Gastroenterol Hepatol. 2014;8:21–28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.